Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera

被引:8
|
作者
Krecak, Ivan [1 ]
Holik, Hrvoje [2 ]
Coha, Bozena [2 ]
Peric, Martina Moric [3 ]
Zekanovic, Ivan [3 ]
Krecak, Marija Valovicic [4 ]
Gveric-Krecak, Velka [1 ]
Lucijanic, Marko [5 ,6 ]
机构
[1] Gen Hosp Sibenik Knin Cty, Dept Internal Med, Stjepana Radica 83, Shibenik 22000, Croatia
[2] Dr Josip Bencevic Gen Hosp, Dept Internal Med, Slavonski Brod, Croatia
[3] Gen Hosp Zadar, Dept Internal Med, Zadar, Croatia
[4] Gen Hosp Sibenik Knin Cty, Dept Psychiat, Shibenik, Croatia
[5] Univ Hosp Dubrava, Zagreb, Croatia
[6] Univ Zagreb, Sch Med, Zagreb, Croatia
关键词
STATINS;
D O I
10.1007/s00277-021-04431-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1335 / 1336
页数:2
相关论文
共 50 条
  • [31] Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions
    Goulart, Hannah
    Mascarenhas, John
    Tremblay, Douglas
    ANNALS OF HEMATOLOGY, 2022, 101 (05) : 935 - 951
  • [32] Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera
    S. Farmer
    V. V. Shanbhogue
    S. Hansen
    C. I. Stahlberg
    H. Vestergaard
    A. P. Hermann
    H. Frederiksen
    Osteoporosis International, 2017, 28 : 677 - 685
  • [33] Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera
    Farmer, S.
    Shanbhogue, V. V.
    Hansen, S.
    Stahlberg, C. I.
    Vestergaard, H.
    Hermann, A. P.
    Frederiksen, H.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (02) : 677 - 685
  • [34] Thrombotic and hemorrhagic complications after surgery in patients with essential thrombocythemia and polycythemia vera.
    Ruggeri, Marco
    Rodeghiero, Francesco
    Tosetto, Alberto
    Castaman, Giancarlo
    Scognamiglio, Francesca
    Finazzi, Guido
    Delaini, Federica
    Mico, Caterina
    Vannucchi, Alessandro M.
    Antonioli, Elisabetta
    De Stefano, Valerio
    Za, Tommaso
    Gugliotta, Luigi
    Tieghi, Alessia
    Mazzucconi, Maria Gabriella
    Santoro, Cristina
    Barbui, Tiziano
    BLOOD, 2006, 108 (11) : 761A - 761A
  • [35] Increased Lipocalin 2 level may have important role in thrombotic events in patients with polycythemia vera and essential thrombocythemia
    Rajnics, P.
    Kellner, A.
    Karadi, E.
    Moizs, M.
    Bodor, Cs.
    Kiraly, P. A.
    Marosvari, D.
    Andrikovics, H.
    Egyed, M.
    LEUKEMIA RESEARCH, 2016, 48 : 101 - 106
  • [36] Upregulation of Thrombo-Inflammatory Pathways May Contribute to Increased Thrombotic Risk in Polycythemia Vera and Essential Thrombocythemia
    Gangaraju, Radhika
    Kim, Soo Jin
    Song, Jihyun
    Swierczek, Sabina
    Thiagarajan, Perumal
    Prchal, Josef T.
    BLOOD, 2016, 128 (22)
  • [37] Polycythemia vera and essential thrombocythemia: algorithmic approach
    Vannucchi, Alessandro M.
    Guglielmelli, Paola
    Tefferi, Ayalew
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (02) : 112 - 119
  • [38] \ Erythromelalgia in patients with essential thrombocythemia and polycythemia vera
    Hou, Jennifer L.
    Onajin, Oluwakemi
    Gangat, Naseema
    Davis, Mark D. P.
    Wolanskyj, Alexandra P.
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 715 - 717
  • [39] Updates in the management of polycythemia vera and essential thrombocythemia
    Bose, Prithvirai
    Verstovsek, Srdan
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [40] Leukocytosis at Diagnosis and the Risk of Subsequent Thrombosis in Patients With Low-Risk Essential Thrombocythemia and Polycythemia Vera
    Gangat, Naseema
    Wolanskyj, Alexandra P.
    Schwager, Susan M.
    Hanson, Curtis A.
    Tefferi, Ayalew
    CANCER, 2009, 115 (24) : 5740 - 5745